Director · ARROWHEAD PHARMACEUTICALS, INC. · Common Stock
Side
A
Value
—
Shares
7,819
Price
—
Executed
Dec 16, 2025
Disclosed
Dec 18, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 16 executedDec 18, 2025 disclosed
ARWR · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 16.6% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lu Hongbo filed this Form 4 reporting a grant or award of ARWR on Dec 16, 2025. It became public on Dec 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Lu Hongbocik:0001767584
Issuer
ARROWHEAD PHARMACEUTICALS, INC.cik:0000879407
Revision history · 0
No field has changed since this record was first ingested.
